Organization
Merz North America
3 clinical trials
Clinical trial
A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Study With an Open-label Extension Period to Investigate the Efficacy and Safety of NT 201 in the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)Status: Completed, Estimated PCD: 2021-04-15
Clinical trial
LONG RUN: LONGitudinal Evaluation and Real-world Evidence of Uniquely Purified incobotulinumtoxinA (Xeomin) in Treatment Naïve ParticipantsStatus: Terminated, Estimated PCD: 2023-05-18
Clinical trial
A Prospective, Randomized, Double-blind, Placebo-controlled, Multi-center Exploratory Study to Investigate NT 201 in the Treatment of Enlarged Pores and Excessive Sebum Production in the FaceStatus: Active (not recruiting), Estimated PCD: 2024-06-01